GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer

This study aimed to investigate the association of the GSTP1 gene polymorphism with the outcomes and toxicities of treatments in breast cancer. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for the association of GSTP1 polymorphism with tumour response and toxicities, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jie, Zhu, Shao-Liang, Liu, Yang, Huang, Xiang-Yang, Su, Dan-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641181/
https://www.ncbi.nlm.nih.gov/pubmed/29069838
http://dx.doi.org/10.18632/oncotarget.18513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641181/
https://www.ncbi.nlm.nih.gov/pubmed/29069838
http://dx.doi.org/10.18632/oncotarget.18513

Ejemplares similares